Concepedia

G. Lahu

GL

Statistics

Publications

11

Citations

269

H-Index

10

Active since

2006

Affiliations

Takeda (United States)(Current)

Deerfield (United States)

King's College London

Eli Lilly (United States)

South London and Maudsley NHS Foundation Trust

G. Lahu is an author at Takeda (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

2006–2020

11

Publications

11

Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults

Marlies A. van Duinen, Anke Sambeth, Pim R.A. Heckman et al. · Neuropharmacology · 2017 · 65 citations · Full text

, , +14

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients

James Gilleen, Farah Yakub, Cate Davison et al. · Psychopharmacology · 2018 · 54 citations · Full text

, , +17

Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide

G. Lahu, Andreas Huennemeyer, Rolf Herzog et al. · International Journal of Clinical Pharmacology and Therapeutics · 2009 · 28 citations

, , +10

Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects

T.D. Bethke, Kristin Westphal, Andrea Weinbrenner et al. · International Journal of Clinical Pharmacology and Therapeutics · 2006 · 21 citations

, , +17

The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

James Gilleen, Judith Nottage, Farah Yakub et al. · Journal of Psychopharmacology · 2020 · 21 citations

, , +17

1–5 of 11